SPIRIT2 trial on dasatinib for AML - safety and side effect management
Venetoclax in combination with ibrutinib: can it control CLL?
Overview of research in Waldenström’s macroglobulinemia therapies
Overview of the CLLR3 trial of obinutuzumab
How can we overcome ibrutinib resistance?